Characterization and determination of the complex between prostate-specific antigen and α₁-protease inhibitor in benign and malignant prostatic diseasesZHANG, W.-M; FINNE, P; LEINONEN, J et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 2000, Vol 60, Num 233, pp 51-58, issn 0085-591XArticle

Neurochemical monitoring of the acutely injured human brainHILLERED, L; PERSSON, L.Scandinavian journal of clinical & laboratory investigation. Supplement. 1999, Vol 59, Num 229, pp 9-18, issn 0085-591XConference Paper

Markers for Cardiac Damage - Current Status and Future TrendsKALLNER, Anders; PANTEGHINI, Mauro; HÖLZEL, Wieland et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1999, Vol 59, Num 230, issn 0085-591X, 182 p.Conference Proceedings

Androgen receptor gene amplification : A novel molecular mechanism for endocrine therapy resistance in human prostate cancerKOIVISTO, P; VISAKORPI, T; KALLIONIEMI, O.-P et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1996, Vol 56, Num 226, pp 57-64, issn 0085-591XArticle

Molecular basis for amyloidosis related to hereditary brain hemorrhageABRAHAMSON, M.Scandinavian journal of clinical & laboratory investigation. Supplement. 1996, Vol 56, Num 226, pp 47-56, issn 0085-591XArticle

IFCC European congress clinical chemistryADLERCREUTZ, H; PENTTILÄ, I; TENHUNEN, R et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1995, Vol 55, Num 223, pp 1-936, issn 0085-591XConference Proceedings

Nordic congress in clinical chemistryKALLNER, Anders; NORMAN, Arne.Scandinavian journal of clinical & laboratory investigation. Supplement. 1994, Vol 54, Num 218, pp 1-94, issn 0085-591XConference Proceedings

Standardizing and reporting results from Mg²⁺ ISEs, with some notes on sample handlingFOGH-ANDERSEN, N; SIGGAARD-ANDERSEN, O.Scandinavian journal of clinical & laboratory investigation. Supplement. 1994, Vol 54, Num 217, pp 89-96, issn 0085-591XConference Paper

Development of criteria for the evaluation of reference method valuesSTÖCKL, D; REINAUER, H.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 212, pp 16-18, issn 0085-591XArticle

Quality assurance for decentralised testing in primary and secondary careBULLOCK, D. G.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 212, pp 58-59, issn 0085-591XArticle

Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometryADLECREUTZ, H; FOTSIS, T; LAMPE, J et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 215, pp 5-18, issn 0085-591XArticle

Ventilation in ARDS and asthma : the optimal blood gas valuesGØTHGEN, I. H; BERTHELSEN, P. G; RASMUSSEN, J. P et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 214, pp 67-73, issn 0085-591XArticle

Report on a common survey in clinical laboratories in Belgium and in the Netherlands : immunoassaysLIBEER, J. C; TERTOOLEN, J. F. W.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 212, pp 39-42, issn 0085-591XArticle

Specificity and detection limit of ten pregnancy testsALFTHAN, H; BJÖRSES, U.-M; TIITINEN, A et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1993, Vol 53, Num 216, pp 105-113, issn 0085-591XConference Paper

Chicken pepsin and the other avian aspartic proteinasesKOSTKA, V.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 210, pp 121-125, issn 0085-591XArticle

Some aspects of structural studies on aspartic proteinasesANDREEVA, N. S.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 210, pp 31-38, issn 0085-591XArticle

Understanding HIV protease : can it be translated into effective therapy against AIDS ?TANG, J; LIN, Y; CO, E et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 210, pp 127-135, issn 0085-591XArticle

2.1.1. A software PC program for evaluation of clinical testsGERHARDT, W; OLSSON, V.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 208, pp 31-33, issn 0085-591XArticle

2.3.1. Unimodal distribution. CommentsLARS ULRIK GERDES.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 208, pp 59-60, issn 0085-591XArticle

3.2. Influence of analytical quality on test results. CommentsDE VERDIER, C.-H.Scandinavian journal of clinical & laboratory investigation. Supplement. 1992, Vol 52, Num 208, pp 93-94, issn 0085-591XArticle

Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancerGADDUCI, A; FERDEGHINI, M; RISPOLI, G et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 207, pp 19-24, issn 0085-591XConference Paper

Epitope analysis of recombinant human thyrotropinMIYAI, K.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 205, issn 0085-591X, p. 139Conference Paper

Serum TATI levels and clinical correlation in tumors of the head and neckRAYO, J. I; GARCIA-TALAVERA, J. R; MARTIN, M et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 207, pp 33-35, issn 0085-591XConference Paper

The antibody/antiserum as an analytical reagent in quantitative immunoassayALBERT, W. H. W.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 205, pp 79-85, issn 0085-591XConference Paper

Tumor-associated trypsin inhibitor (TATI) in primary esophagel carcinomaGION, M; MIONE, R; TREMOLADA, C et al.Scandinavian journal of clinical & laboratory investigation. Supplement. 1991, Vol 51, Num 207, pp 37-41, issn 0085-591XConference Paper